SCHEMBL5459751

SCHEMBL5459751

COc1ccc(S(=O)(=O)C(F)(Nc2ccc(Cl)cc2Cc2c(F)cccc2F)C(=O)O)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TP53 P04637 2/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
PKM P14618 3/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 4/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
F2 P00734 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCR1 P32246 1/20 0.38
CCR2 P41597 1/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5459740 0.80 ALDH1A1 (0.44) ALDH1A1TP53MEN1KMT2APKM
SCHEMBL3246071 0.80 ALDH1A1 (0.61) ALDH1A1TP53MEN1KMT2APKM
SCHEMBL3256517 0.78 ALDH1A1 (0.51) ALDH1A1TP53KMT2APKMTSHR
SCHEMBL3250405 0.77 NPC1 (0.48) ALDH1A1TP53MEN1KMT2APKM
SCHEMBL4863941 0.76 ALDH1A1 (0.48) ALDH1A1TP53MEN1KMT2ATSHR
SCHEMBL3247363 0.75 PKM (0.43) ALDH1A1TP53MEN1KMT2APKM
SCHEMBL4867720 0.75 ALDH1A1 (0.49) ALDH1A1TP53KMT2APKMTSHR
SCHEMBL4871023 0.74 PKM (0.52) ALDH1A1TP53MEN1KMT2APKM
SCHEMBL3243765 0.74 PKM (0.46) ALDH1A1TP53MEN1KMT2APKM
SCHEMBL3256098 0.73 PKM (0.47) ALDH1A1TP53MEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HCRTR2, GIPR, SSTR2 ALDH1A1 2179/4885TP53 4876/4885MEN1 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.